Evidence map›Paper›PMID 40873931›Full record

ArticleFrontiers in aging neuroscience2025

A model to address healthcare gaps and poor research participation in Hispanic patients with Parkinson's disease.

M Felice Ghilardi, Alessandro Di Rocco, Jennifer Fearday, Donna Sperlakis, Maria Lima, Nora Vanegas-Arroyave, Elisa Tatti, Marcelo Arroyave, Evelyn Stevens, Denise Hernandez and 3 more

Abstract read
In one paragraph

Article in Frontiers in aging neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

M Felice GhilardiDepartment of Molecular, Cellular & Biomedical Sciences, CUNY School of Medicine, New York, NY, United States.
Alessandro Di RoccoMovement Disorders Division, Department of Neurology, Northwell Health, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Long Island, NY, United States.
Jennifer FeardayParkinson's Foundation, New York, NY, United States.
Donna SperlakisParkinson's Foundation, New York, NY, United States.
Maria LimaDepartment of Molecular, Cellular & Biomedical Sciences, CUNY School of Medicine, New York, NY, United States.
Nora Vanegas-ArroyaveDepartment of Neurology, Baylor College of Medicine, Houston, TX, United States.
Elisa TattiDepartment of Molecular, Cellular & Biomedical Sciences, CUNY School of Medicine, New York, NY, United States.
Marcelo ArroyaveDepartment of Molecular, Cellular & Biomedical Sciences, CUNY School of Medicine, New York, NY, United States.
Evelyn StevensParkinson's Foundation, New York, NY, United States.
Denise HernandezDallas Fort Worth Community Health Worker Association, Dallas, TX, United States.
Paulina Latapi-GonzalezDepartment of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.
Meri-Margaret DeoudesParkinson's Foundation, New York, NY, United States.
Christiana EversParkinson's Foundation, New York, NY, United States.

Funding

Research Center in Minority Institutions (RCMI) at City CollegeU54MD017979 · NIMHD · CITY COLLEGE OF NEW YORK · PI M. Felice Marina GHILARDI · 2024 to 2026
$15.9M
Investigating neuroanatomical underpinnings of apathy in ADRD through neuroimaging and electrical manipulationR01MH127200 · NIMH · BAYLOR COLLEGE OF MEDICINE · PI VANEGAS-ARROYAVE, NORA · 2021 to 2025
$3.5M
NIMHD NIH HHS U54 MD017979NIMH NIH HHS R01 MH127200
6 · The paper itself

Abstract

Parkinson's disease (PD), a progressive neurodegenerative disorder, manifests with motor and non-motor symptoms. Despite similar incidence, in the US, disease management of Hispanic patients with PD is poorer than that of White non-Hispanics, and their participation in clinical trials does not reflect expected values (well below 5% vs. expected values around 20%). Together with other evidence, these observations are expressions of poor healthcare in Hispanic patients with PD, suggesting underutilization of proper healthcare, social and economic disadvantage, and other factors. The scant participation of Hispanic patients in clinical trials further exacerbates care inadequacy. In this paper, after reviewing evidence of healthcare gaps in Hispanic patients with PD and their low participation in research, we present a comprehensive model for reaching these patients and their caregivers, educating them on PD, and engaging them in research. This model is based on the work and experience of the Parkinson's Foundation, which over the years, has worked to increase PD awareness in Hispanic communities. This model is based on the training of

Indexed as

community health workercommunity interventionhealthcare improvementHispanic/LatinoLatinoParkinson diseasepromotores de saludresearch participation

Identifiers

PMID40873931
PMCPMC12378734

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.